Tag Archives: Cipla
New Delhi: Mumbai-based Lupin Pharmaceuticals has topped the ‘India’s Most Reputed Pharmaceutical Brands’ list. Sun Pharma is the second most reputed brand with a 52% lower Brand Rep Score and Cipla is at third position with a Brand Rep Score 28% behind the previous ranked. At India’s fourth Most Reputed Pharma Brand is Dr Reddy’s behind 71% in terms of Brand Rep points.
London: The sprouting “free health check-up camps” in India are just a tactic of pharmaceutical companies to push their products and are in violation of the Medical Council of India (MCI) guidelines, says a special investigative report in the British Medical Journal.
New Delhi: In a setback to Cipla, the Delhi High Court on Friday held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche’s patent in lung cancer drug erlotinib hydrochloride, sold under the name of Tarceva.
Chennai: Indian pharmaceutical majors are expected to be on the lookout for more overseas buys as domestic drug makers have joined the consolidation phase in the global pharma industry, a research report from Jefferies states.
Mumbai (IANS): The British subsidiary of Indian drug major Cipla Ltd has acquired 51 percent equity stake in Uganda-based Quality Chemicals Ltd for $30 million (Rs 191 crore) in tranches from its current shareholders.
Nairobi: Indian drug major Cipla is working with a global health NGO to manufacture the first user-friendly paediatric HIV/AIDS drug targeted at millions of African children who are currently being forced to take medicine that is unpalatable — to say the least.
Mumbai: Cipla, a leading generic pharmaceutical company, on Wednesday said it has launched the first biosimilar of Etanercept under the brand name Etacept for the treatment of rheumatic disorders in India.
Mumbai: Cipla, one of India’s largest generic-drug manufacturers, on Thursday said it is reducing prices of three of its anti-cancer drugs by up to 63 per cent. According to the company, the move is part of its commitment to make medicines affordable and accessible, particularly in anti-cancer medication.
New Delhi: Swiss drug company Hoffmann-La Roche on Monday challenged the relief awarded by a single judge of the Delhi High Court to Indian pharmaceutical major Cipla which held that it (Cipla) has not infringed upon the patent right of Roche on a cancer drug.